Clinicopathological correlations in behavioural variant frontotemporal dementia
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Accurately predicting the underlying neuropathological diagnosis in patients with behavioural variant frontotemporal dementia (bvFTD) poses a daunting challenge for clinicians but will be critical for the success of disease-modifying therapies. We sought to improve pathological prediction by exploring clinicopathological correlations in a large bvFTD cohort. Among 438 patients in whom bvFTD was either the top or an alternative possible clinical diagnosis, 117 had available autopsy data, including 98 with a primary pathological diagnosis of frontotemporal lobar degeneration (FTLD), 15 with Alzheimer's disease, and four with amyotrophic lateral sclerosis who lacked neurodegenerative disease-related pathology outside of the motor system. Patients with FTLD were distributed between FTLD-tau (34 patients: 10 corticobasal degeneration, nine progressive supranuclear palsy, eight Pick's disease, three frontotemporal dementia with parkinsonism associated with chromosome 17, three unclassifiable tauopathy, and one argyrophilic grain disease); FTLD-TDP (55 patients: nine type A including one with motor neuron disease, 27 type B including 21 with motor neuron disease, eight type C with right temporal lobe presentations, and 11 unclassifiable including eight with motor neuron disease), FTLD-FUS (eight patients), and one patient with FTLD-ubiquitin proteasome system positive inclusions (FTLD-UPS) that stained negatively for tau, TDP-43, and FUS. Alzheimer's disease was uncommon (6%) among patients whose only top diagnosis during follow-up was bvFTD. Seventy-nine per cent of FTLD-tau, 86% of FTLD-TDP, and 88% of FTLD-FUS met at least 'possible' bvFTD diagnostic criteria at first presentation. The frequency of the six core bvFTD diagnostic features was similar in FTLD-tau and FTLD-TDP, suggesting that these features alone cannot be used to separate patients by major molecular class. Voxel-based morphometry revealed that nearly all pathological subgroups and even individual patients share atrophy in anterior cingulate, frontoinsula, striatum, and amygdala, indicating that degeneration of these regions is intimately linked to the behavioural syndrome produced by these diverse aetiologies. In addition to these unifying features, symptom profiles also differed among pathological subtypes, suggesting distinct anatomical vulnerabilities and informing a clinician's prediction of pathological diagnosis. Data-driven classification into one of the 10 most common pathological diagnoses was most accurate (up to 60.2%) when using a combination of known predictive factors (genetic mutations, motor features, or striking atrophy patterns) and the results of a discriminant function analysis that incorporated clinical, neuroimaging, and neuropsychological data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because isolated rATL atrophy is highly predictive of TDP-C pathology, recent studies have highlighted the importance of characterizing and isolating this syndrome from other FTD syndromes.6”
From Automated Speech Analysis to Differentiate Frontal and Right Anterior Temporal Lobe Atrophy in Frontotemporal Dementia (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternatively, lesions of the Alzheimer type are frequently observed as copathology in post-mortem examination of people who had other neurodegenerative diseases.40,41,94,96”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [96]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, loss of function of GRN alkalinizes lysosomes, while PD-associated mutations in TMEM175, a lysosomal proton leak channels, hyper-acidifies lysosomes.129,130”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [129]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, loss of function of GRN alkalinizes lysosomes, while PD-associated mutations in TMEM175, a lysosomal proton leak channels, hyper-acidifies lysosomes.129,130”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [129]
Experimental — accuracy not yet measuredIn the citing paper
“This biomarker positivity is particularly ambiguous in the case of behavioural or dysexecutive variants, corticobasal syndrome, and semantic or non-fluent variants of primary progressive aphasia, in which the presence of positive Alzheimer’s disease biomarkers can be considered either as Alzheimer’s disease copathology or atypical forms of Alzheimer’s disease94,96,98,99 (appendix p 2).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 3×
“This determination was made by the reviewing clinician as has been done in prior papers establishing the sensitivity and interrater reliability of these criteria (Rascovsky et al., 2011; Lamarre et al., 2013).”
BackgroundMethodSelf-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · cited 1×
“Patients were classified into FTLD major molecular classes (tau, TDP-43, or FUS) and subtypes (Mackenzie et al., 2010, 2011), Alzheimer’s disease (Hyman and Trojanowski, 1997; Hyman et al., 2012), or amyotrophic lateral sclerosis (ALS).”
BackgroundSelf-citationAppelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
Self-citation
Cited by
Items 201–300 of 325
Butler, P. M., Chiong, W., Perry, D. C., Miller, Z., Gennatas, E. D., Brown, J. A., Pasquini, L., Karydas, A., Dokuru, D. R., Coppola, G., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101822 · Cited by 7
Self-citationLaughter as a paradigm of socio-emotional signal processing in dementia
Sivasathiaseelan, H., Marshall, C. R., Benhamou, E., van Leeuwen, J. E. P., Bond, R. L., Russell, L. L., Greaves, C. V., Moore, K. M., Hardy, C. J. D., Frost, C. D., et al. (2021) · Cortex · doi:10.1016/j.cortex.2021.05.020 · Cited by 8
Palmieri, I., Poloni, T. E., Medici, V., Zucca, S., Davin, A., Pansarasa, O., Ceroni, M., Tronconi, L., Guaita, A., Gagliardi, S., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071687 · Cited by 8
“Nonetheless, the distinction between pathologies is not absolute, as it occurs in the frontal variant of AD [20,21], and in AD associated with LATE.”
BackgroundOhm, D. T., Rhodes, E., Bahena, A., Capp, N., Lowe, M., Sabatini, P., Trotman, W., Olm, C. A., Phillips, J., Prabhakaran, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1245886 · Cited by 6
Coulborn, S., Roy, A. R. K., Sokołowski, A., Cryns, N. G., Lago, A. L., Cobigo, Y., Rojas, J. C., Spina, S., Grinberg, L. T., Rankin, K. P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70771 · Cited by 6
“8,9 Additional tools beyond structural imaging are needed to improve diagnostic accuracy.”
Self-citationDecision making in frontotemporal dementia: neuropsychological and neuroimaging assessments
Haghighi, S. T., Bertasini, C., Picari, R., & Paolone, G. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1632054 · Cited by 7
The Brain Donation Program in South Korea
Kim, Y., Suh, Y., Kim, S. J., Bae, M. H., Kim, J. B., Kim, Y., Choi, K., Huh, G. Y., Kim, E., Lee, J. S., et al. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.10.1197 · Cited by 6
“Despite attempts to associate these FTD clinical syndromes with specific frontotemporal lobar degeneration neuropathological diagnoses, to date, no such correlation have proven invariant.(24,25) However, clinicopathologic correlation study is very important in cases of FTD syndrome.”
BackgroundSelf-citationLate-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases
Resende, E. D. P. F., Ketelle, R., Karydas, A., Allen, I. E., Grinberg, L. T., Spina, S., Seeley, W. W., Perry, D. C., Miller, B. L., & Naasan, G. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215369 · Cited by 8
Self-citationAmyloid-PET–Positive Patient With bvFTD: Wrong Diagnosis, False Positive Scan, or Copathology?
Langheinrich, T., Kobylecki, C., Jones, M. S., Thompson, J. C., Snowden, J. S., Hinz, R., Pickering-Brown, S. M., Mann, D. M. A., Roncaroli, F., Herholz, K., et al. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001049 · Cited by 6
“A diagnosis of bvFTD may be changed to AD when amyloid-PET is positive, a decision supported by cases diagnosed with bvFTD but found to have AD at post-mortem [4].”
BackgroundMethodInfluentialDisinhibition in dementia related to reduced morphometric similarity of cognitive control network
Jenkins, L. M., Heywood, A. A., Gupta, S. M., Kouchakidivkolaei, M., Sridhar, J., Rogalski, E. J., Weıntraub, S., Popuri, K., Rosen, H. J., Wang, L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae124 · Cited by 7
“12 As such, a transdiagnostic understanding of common symptoms that cross conventional disease boundaries is warranted, as mechanistic explanations may not exist at the level of molecular pathology 13 but likely do at the network level.”
BackgroundSelf-citationSelective cellular and regional vulnerability in frontotemporal lobar degeneration: a scoping review
Ravasia, K., & Hirsch‐Reinshagen, V. (2025) · Free Neuropathology · doi:10.17879/freeneuropathology-2025-5812 · Cited by 6
Differentiating sporadic frontotemporal dementia from late-onset primary psychiatric disorders
de Boer, S. C. M., Riedl, L., Braak, S., Fenoglio, C., Foxe, D., Carrick, J., Landín-Romero, R., Matis, S., Chatterton, Z., Rue, I., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf199 · Cited by 5
Self-citationTAF15 amyloids propagate via defined motifs in a prion-like fashion
Konstantoulea, K., Gadhe, L. G., Goodavish, F., Gupta, A., Tagad, H. D., Vaquer‐Alicea, J., Ghayal, N. B., Roemer, S. F., Deture, M. A., Nana, A. L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75607-3 · Cited by 5
“Like FUS and EWSR1, it contains an N-terminal glycine-and tyrosine-rich low-complexity domain (LCD) capable of phase separation and stress granule assembly, followed by an RNA recognition motif and C-terminal zinc fi nger 21,22 .”
Self-citationTuovinen, T., Häkli, J., Rytty, R., Krüger, J., Korhonen, V. O., Järvelä, M., Helakari, H., Kananen, J., Nikkinen, J., Veijola, J., et al. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241262583 · Cited by 5
Self-citationAtypical Parkinsonian Disorders
Olfati, N., Akhoundi, F. H., & Litvan, I. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2024.12.006 · Cited by 6
Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration
Long, Z., Irish, M., Hodges, J. R., Halliday, G. M., Piguet, O., & Burrell, J. R. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.004 · Cited by 5
Battista, M. E. D., Dell’Acqua, C., Baroni, L., Fenoglio, C., Galimberti, D., & Gallucci, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180524 · Cited by 5
Asken, B. M., Thomas, K. R., Lee, A. K. W., Davis, J. D., Malloy, P. F., Salloway, S., & Initiative, A. D. N. (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617719001346 · Cited by 5
“, 2017) and, when present, cognitive impairment is not universally the prototypic AD presentation of “rapid forgetting” (Ossenkoppele et al., 2015; Perry et al., 2017; Phillips et al., 2018).”
BackgroundFredes-Roa, C., Gutiérrez-Barría, F., Ramírez-Bruna, C., Cigarroa, I., Martella, D., Julio–Ramos, T., Méndez‐Orellana, C., & Toloza–Ramirez, D. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.07.007 · Cited by 7
Corticobasal degeneration: An update
Révész, T., Lees, A. J., & Morris, H. R. (2024) · Ideggyógyászati Szemle · doi:10.18071/isz.77.0379 · Cited by 9
“Recent case series have reported that 6-9% of clinically defined bvFTD cases have underlying CBD pathology , 34 .”
Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies
Nementzik, L. R., Kavanagh, T., Genoud, S., & Drummond, E. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70270 · Cited by 4
“PiD is characterised by tau pathology and severe neuronal loss in the frontal and temporal lobes, often seen as focal ‘knife-edge’ atrophy on MRI (Dickson 1998; Irwin et al. 2016; Perry et al. 2017).”
Journe‐Mallet, I., Gouju, J., Etcharry‐Bouyx, F., Chauviré, V., Guillet, V., Scherer‐Gagou, C., Prundean, A., Godard, S., Lecluse, A., Cassereau, J., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13138 · Cited by 5
Martínez‐Dubarbie, F., López‐García, S., Andrés-Gómez, M., Lage, C., Pozueta, A., García‐Martínez, M., Kazimierczak, M., Bravo, M., Jiménez-Bonilla, J. F., Banzo, I., et al. (2020) · Neurocase · doi:10.1080/13554794.2020.1842464 · Cited by 4
Locus Coeruleus Degeneration Differs Between Frontotemporal Lobar Degeneration Subtypes
Matti, N., Javanshiri, K., Haglund, M., Saenz-Sardà, X., & Englund, E. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220276 · Cited by 4
Li, H., Xiong, L., Xie, T., Wang, Z., Li, T., Zhang, H., Wang, L., Yu, X., & Wang, H. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac487 · Cited by 5
Criterios diagnósticos en la enfermedad demencial ¿Qué hay de nuevo?
Labos, E., Bavec, C. V., Cristalli, D. O., Deschle, F., Isaac, C. F., Dorman, G. S., Ollari, J., Rubiño, V., & Russo, M. J. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i160.460 · Cited by 6
Suzuki, Y., Adachi, T., Sakuwa, M., Sakata, R., Takigawa, H., Hasegawa, M., & Hanajima, R. (2022) · Neuropathology · doi:10.1111/neup.12815 · Cited by 5
“In 2014, Tatsumi et al. reported that 26.7% of PSP patients had AGD.12 PSP patients with AGD stage III show left– right asymmetry in deposition of AGs, and that patients having more AG deposits on the left side tend to show more cognitive decline.14 In our patient, AGs were relatively abundant and showed right-predomi…”
BackgroundInfluentialNatural language processing and modeling of clinical disease trajectories across brain disordersPreprint
Mekkes, N., Groot, M., Wehrens, S. M. T., Hoekstra, E., Herbert, M. K., Brummer, M. L., Wever, D. D., Eggen, B. J. L., Rozemüller, A. J. M., Huitinga, I., et al. (2022) · medRxiv · doi:10.1101/2022.09.22.22280158 · Cited by 4
Lane-Donovan, C., Paredes, M., & Kao, A. W. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102854 · Cited by 3
Self-citationAltered Empathy Processing in Frontotemporal Dementia
Lindberg, O. E., Li, T., Lind, C., Vestberg, S., Almkvist, O., Stiernstedt, M., Ericson, A., Bogdanović, N., Hansson, O., Harper, L., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.48601 · Cited by 3
MRI ‐ DTI Biomarkers Along the Continuum of Behavioral Variant Frontotemporal Dementia
Michelutti, M., Huppertz, H., Anderl‐Straub, S., Volkmann, H., Urso, D., Tafuri, B., Nigro, S. L., Manganotti, P., Rosenbohm, A., Ludolph, A. C., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70438 · Cited by 4
Chatzidimitriou, E., Sioka, C., Aretouli, E., Iakovou, I. P., Ioannidis, P., & Moraitou, D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1737054 · Cited by 3
“While bvFTD is not classically characterized by primary memory deficits, dysfunction in medial temporal and limbic regions has been reported to contribute to episodic memory impairments (Perry et al., 2017).”
Vergel, J., Robledo, M. E. B., González, C. A. H., Escobar, C. S. M., Otalvaro, S. O., Tobón, J. D. S., de la Pava, P. M. A., & Alvarez, J. J. (2021) · Case Reports in Neurology · doi:10.1159/000513851 · Cited by 3
Clinical Trial Development in Frontotemporal Lobar Degeneration
Ljubenkov, P. A., & Boxer, A. L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.019 · Cited by 3
Self-citationThe association between lifelong personality and clinical phenotype in the FTD-ALS spectrum
Vinceti, G., Carbone, C., Gallingani, C., Fiondella, L., Salemme, S., Zucchi, E., Martinelli, I., Gianferrari, G., Tondelli, M., Mandrioli, J., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1248622 · Cited by 3
Corticobasal degeneration with visual hallucination as an initial symptom: A case report
Yoshida, K., Adachi, T., Suzuki, Y., Sakuwa, M., Fukuda, H., Hasegawa, M., Adachi, Y., Miura, H., & Hanajima, R. (2024) · Neuropathology · doi:10.1111/neup.12963 · Cited by 3
“17 Hallucinations may not, in fact, be uncommon symptoms of CBD and perhaps are more likely in patients with atypical CBD who do not pre-sent with corticobasal syndrome.”
Urso, D., Giannoni‐Luza, S., Mondello, S., & Logroscino, G. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081935 · Cited by 3
“18 Over the years, diagnostic criteria for bvFTD have undergone revisions, trying to address these challenges and improve diagnostic accuracy (table 1).”
Saitoh, Y., Imabayashi, E., Mizutani, M., Tsukamoto, T., Hasegawa, M., Saito, Y., Matsuda, H., & Takahashi, Y. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11121-y · Cited by 3
Toller, G., Zitser, J., Sukhanov, P., Grant, H. E., Miller, B. L., Kramer, J. H., Rosen, H. J., Rankin, K. P., & Grinberg, L. T. (2021) · Neurocase · doi:10.1080/13554794.2021.1936072 · Cited by 3
Self-citationFrontotemporal lobar degeneration
Kim, B., Viera-Ortiz, A., Phan, J. M., Irwin, D. J., & Lee, E. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00041-1 · Cited by 3
Ransmayr, L., Fuchs, A., Ransmayr-Tepser, S., Kommenda, R., Kögl, M., Schwingenschuh, P., Fellner, F. A., Guger, M., Eggers, C., Darkow, R., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02524-2 · Cited by 3
Utility of empathy informant report in FTD differential diagnosis
Lane, C., Lee, M., Lowe, J., Bolton, C. J., & Pyykkonen, B. (2022) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617722000704 · Cited by 3
“Sample characteristics and IRI scores by diagnostic group n Age*** Sex (M/F)* Education (years) IRI-PT*** IRI-EC*** bvFTD 406 62.63 (8.39) 247/159 15.62 (2.74) 13.75 (5.34) 20.08 (6.82) Non-bvFTD 385 65.83 (8.13) 203/182 15.57 (2.67) 19.06 (6.68) 25.26 (6.41) nfvPPA 68 66.56 (8.50) 31/37 15.28 (2.38) 21.19 (6.88) 26.1…”
BackgroundResultInfluentialVora, N., Patel, P. K., Marsool, M. D. M., Marsool, A. D. M., Sunasra, R., Ladani, P., Pati, S., Khoont, D., Prajjwal, P., & Ranjan, R. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.101863 · Cited by 4
Degenerative dementias: a question of syndrome or disease?
Bayón, A. R. (2021) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.03.027 · Cited by 4
How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
Donato, L., Mordà, D., Scimone, C., Alibrandi, S., D’Angelo, R., & Sidoti, A. (2023) · Biomedicines · doi:10.3390/biomedicines11072035 · Cited by 3
How far can biomarkers take us in neurodegenerative disorders?
Husain, M. (2017) · Brain · doi:10.1093/brain/awx307 · Cited by 3
“For example, a large study of behavioural variant FTD in this issue of Brain presents findings that show how diverse pathologies and genetic mutations can all lead to the same clinical diagnosis (Perry et al., 2017).”
BackgroundFrontotemporal Dementia and the Sagging Brain
Julayanont, P., & Wicklund, M. (2022) · Neurology · doi:10.1212/wnl.0000000000200613 · Cited by 3
Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
Keersmaecker, S. D., Meyer, S. D., & Vandenberghe, R. R. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70018 · Cited by 3
Exploring the phenotypic spectrum of frontotemporal lobar degeneration
Patel, J., Eisenberg-Godsey, S. R., & Tipton, P. W. (2026) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.109796 · Cited by 2
Demencias degenerativas: ¿un dilema de síndromes o de enfermedades?
Bayón, A. R. (2019) · Neurología · doi:10.1016/j.nrl.2019.03.016 · Cited by 3
Aguzzoli, C. S., Battista, P., Hadad, R., Borges, Y. F. F., Schilling, L. P., & Miller, B. L. (2022) · Neurocase · doi:10.1080/13554794.2022.2135448 · Cited by 2
“(Perry et al., 2017).”
BackgroundSelf-citationThe guaranteed euros: Probabilistic discounting in behavioural‐variant frontotemporal dementia
Boutoleau‐Bretonnière, C., Kapogiannis, D., & Haj, M. E. (2023) · Journal of Neuropsychology · doi:10.1111/jnp.12357 · Cited by 2
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset
Losa, M., Garbarino, S., Cirone, A., Argenti, L., Lombardo, L., Calizzano, F., Girtler, N. G., Brugnolo, A., Mattioli, P., Bauckneht, M., et al. (2025) · Cortex · doi:10.1016/j.cortex.2025.01.011 · Cited by 2
Coulborn, S., Schafer, R., Roy, A. R. K., Sokołowski, A., Cryns, N. G., Leichter, D., Lago, A. L., Ramos, E. M., Cobigo, Y., Spina, S., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70014 · Cited by 2
“Increased dorsality in TDP-A compared to TDP-B cases is supported by research observing significant atrophy in dorsal regions in TDP-A [4, 28, 42].”
InfluentialSelf-citationDiagnostic positif et étiologique des démences frontotemporales
Lebouvier, T., Bertoux, M., Leroy, M., Lebert, F., Deramecourt, V., & Pasquier, F. (2019) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2019.02.012 · Cited by 5
ApoE: A Risk Factor for Dementia
Jeelani, H., Nabi, J., Akhter, Y., Tabasum, N., Afroze, D., Pottoo, F. H., & Ali, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_1 · Cited by 2
Lima, M., Tábuas‐Pereira, M., Durães, J., Vieira, D., Faustino, P., Baldeiras, I., & Santana, I. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220897 · Cited by 2
Sheng, J., Yang, Z. X., Zhang, Q., Wang, L., & Xin, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18121 · Cited by 1
Clark, C. N., Poole, N. A., Isaacs, J. D., MacKinnon, A. D., Rich, P. M., Bridges, L., Jaunmuktane, Z., & Galizia, E. C. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12973 · Cited by 1
“AGD is four-repeat tauopathy and included in the FTLD-tau group [6, 10].”
BackgroundPerry, A., Hughes, L. E., Adams, N., Naessens, M., Kloosterman, N. A., Rouse, M. A., Murley, A. G., Street, D., Jones, P. S., & Rowe, J. B. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103671 · Cited by 2
“However, there are also marked differences in their underlying molecular pathology (Boeve et al., 2022; Gazzina et al., 2019; Perry et al., 2017) and degree of atrophy (Grossman et al., 2023).”
BackgroundDiagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
Shimasaki, R., Kurihara, M., Ishibashi, K., Tokumaru, A. M., Ishii, K., & Iwata, A. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70025 · Cited by 1
Validation of criteria for frontotemporal dementia with right anterior temporal lobe predominance
Jung, N., Kim, S., Seong, J., Na, D. L., Seo, S. W., Yun, J., Lee, E. H., Shin, D., Kang, H., Kang, S. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70443 · Cited by 1
“5,6,15,36 The reason for the lack of controversy over the left temporal variant of FTD is that there are already well-defined syndromes, svPPA and non-fluent/agrammatic variant PPA (nfvPPA), and the remaining patients with left temporal involvement are grouped as bvFTD.”
Self-citationBoyle, R. T., Dehghani, N., Emrani, S., Wadhwani, A. R., Matyi, M. A., Cousins, K. A. Q., Rhodes, E., Nelson, B., Stites, S. D., Xie, S. X., et al. (2025) · Alzheimer s & Dementia Behavior & Socioeconomics of Aging · doi:10.1002/bsa3.70045 · Cited by 1
“2,3 There is substantial heterogeneity in the progression of bvFTD across individuals, 4 with a median survival from symptom onset of ~10 years reported in clinical cohorts, 5 although a lower median survival of ~6 years is reported in autopsy-confirmed FTLD cases.”
Tahedl, M., Kleinerová, J., McKenna, M. C., Siah, W. F., Hardiman, O. M., Hengeveld, J. C., Doherty, M. A., McLaughlin, R. L., Tan, E. L., Hutchinson, S., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13552-9 · Cited by 1
“ALS-FTD is primarily associated with pTDP-43 [33], svPPA results from TDP-43-C aggregates [34], nfvPPA is typically associated with 4R tau [35], and the molecular profile of bvFTD is heterogeneous [36].”
Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions
Casile, A., Sapienza, J., Vasciaveo, V., Barzon, B., Nasini, S., Guarato, G., Ave, C., Martini, F., Bosia, M., & Comai, S. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.04.003 · Cited by 1
Quantitative assessment of brain atrophy in bvFTD: Implications for diagnostic conversion
Beydoun, C., Quang, H., Matis, S., Hazelton, J. L., Carrick, J., Fumagalli, G., Piguet, O., & Landín-Romero, R. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70307 · Cited by 1
Comorbidity patterns and sex differences in late-onset Alzheimer’s disease using electronic records
Katsuhara, Y., Khan, U., Miller, Z., Allen, I. E., Oskotsky, T., Sirota, M., & Tang, A. (2026) · iScience · doi:10.1016/j.isci.2026.117753 · Cited by 1
Self-citationGenetic contributions to sporadic frontotemporal dementia
Carr, J. S., Sirkis, D. W., & Yokoyama, J. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00005-0 · Cited by 1
Hisama, F. M., & Bird, T. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817344-2.00019-8 · Cited by 1
Douglas, V. C., & Josephson, S. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819306-8.00062-9 · Cited by 1
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
Corticobasal degeneration preceded by cognitive impairment and apathy: An autopsy case report
Hirose, S., Kobayashi, R., Hatakeyama, S., Kawakatsu, S., Suzuki, A., Kawanishi, C., & Utsumi, K. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70174 · Cited by 1
Frontotemporal Lobar Degeneration
Filippi, M., & Agosta, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-66773-3_3 · Cited by 2
MRI-Based Multi-Class Relevance Vector Machine Classification of Neurodegenerative DiseasesPreprint
Younes, K., Cobigo, Y., Wolf, A. A., Kornak, J., Rankin, K. P., Beg, M. F., Wang, L., & Rosen, H. J. (2024) · medRxiv · doi:10.1101/2024.10.07.24315054 · Cited by 3
“MRI can aid the diagnosis of neurodegenerative diseases and to some extent help predict the underlying neuropathology [68, 71].”
BackgroundSelf-citationUsing Cerebrospinal Fluid Improves Detection of Individual Brain AtrophyPreprint
Howard, C., Barotono, S., Hassanzadeh, E., Burt, G., Turner, J., Friedrich, H., Friedrich, M. U., Phan, T. X., Drew, W., Larivière, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6423862/v1 · Cited by 1
Multimodal semantic knowledge of emotion concepts in frontotemporal dementiaPreprint
Montembeault, M., Borghesani, V., Miller, Z., Mandelli, M. L., Pillai, J., Tran, S. T., Bogley, R., Millanski, C., Ezzes, Z., Ratnasiri, B. M., et al. (2026) · medRxiv · doi:10.64898/2026.01.12.26343893 · Cited by 1
Self-citationSmith, C. (2020) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.77862
Frontotemporal Dementia-Motor Neuron Disease: disease continuum or distinct entity?
Long, Z. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Zhang, G.-B., Huang, H.-W., Wang, Y., Zhang, X., Li, H.-Y., Duan, Y., Chen, H., Liu, Y., Jing, B., & Lin, S. (2021) · Research Square · doi:10.21203/rs.3.rs-282875/v1
Diagnostic brain imaging and blood biomarkers for early frontotemporal lobar degeneration
Cajanus, A. (2020) · UEF eRepo (University of Eastern Finland)
Deramecourt, V. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.014 · Cited by 1
Young, R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc242.pub2
Shinagawa, S., Kawakami, I., Takasaki, E., Shigeta, M., Arai, T., & Ikeda, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215516
Case Study 2: A 60-Year-Old Man With Progressive Deficits in Language Output
Thurin, K., Patel, V., Perez, D. L., Dickerson, B. C., Hochberg, D., Quimby, M., Miller, M. B., Feany, M. Β., Silbersweig, D., McGinnis, S. M., et al. (2022) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22010013
FRONTOTEMPORALINĖS DEMENCIJOS PASIREIŠKIMAS NEUROPSICHIATRINIAIS SIMPTOMAIS: KLINIKINIS ATVEJIS
Valčiukienė, E., & Vilkas, V. (2023) · Health Sciences · doi:10.35988/sm-hs.2023.011
Backstage of Neurodegenerative Disease Revealed by Nuclear Medicine Examinations
Kobayashi, R., Kawakatsu, S., Morioka, D., Sakamoto, K., Hayashi, H., & Suzuki, A. (2023) · Higher Brain Function Research · doi:10.2496/hbfr.43.12
Ollari, J., Deschle, F., Rubiño, V., Blanco, R., Ciufia, N., & Delembert, W. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i161.487
Miller, B. L., Robertson, I. H., Kavanagh, N., & Valcour, V. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4619-2
Self-citationMemory in Frontotemporal Dementia
Keret, O., Lindbergh, C. A., & Miller, B. L. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190917982.013.60
Self-citationMihailescu, S., Hlava, Q., Cook, P. A., Mandelli, M. L., Lee, S. E., Boeve, B. F., Dickerson, B. C., Gorno‐Tempini, M. L., Rogalski, E. J., Grossman, M., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1452944
“…clinical syndromes are typically associated with FTLD-tau when sporadic (sFTLD-tau), such as PSP (7, 8), as well as naPPA (1, 4, 9) and CBS (1, 10, 11) once Alzheimer’s Disease has been ruled out (12). bvFTD can be associated with either sFTLD-tau or sFTLD-TDP with similar frequency (1, 13, 14).”
BackgroundSelf-citationClinical Diagnosis of Alzheimer’s Disease
Güleç, Z. E. K., & Bozluolçay, M. (2024) · doi:10.69860/nobel.9786053359166.5
Chen, A., Daffner, K. R., & Gale, S. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-12642-0.00015-3
Utilização da ocitocina intranasal na Demência Frontotemporal: uma revisão sistemática integrativa
Bittencourt, R. J., Nobre, T. M., Cavalcante, P. A. Y., de Souza, G., & Barbosa, I. G. (2024) · Revista Neurociências · doi:10.34024/rnc.2024.v32.19479
Language in behavioral variant frontotemporal dementia
Géraudie, A., & Montembeault, M. (2025) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780198888482.013.0017
The Behavioral Variant of Frontotemporal Dementia: Preclinical to Advanced Dementia
Illán‐Gala, I., & Miller, B. L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.011
Self-citationTreatment of Frontotemporal Dementias
Chen, D., VandeVrede, L. A., & Boxer, A. L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.022
Self-citationMagnetic Resonance Imaging in Dementia
Anastassiadis, C., Rosen, H. J., & Tartaglia, M. C. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.007
Self-citationLiu, X. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.106430
Metadata
- Authors
- Perry, D. C., Brown, J. A., Possin, K. L., Datta, S., Trujillo, A., Radke, A., Karydas, A., Kornak, J., Sias, A. C., Rabinovici, G. D., Gorno-Tempini, M. L., Boxer, A. L., De May, M., Rankin, K. P., Sturm, V. E., Lee, S. E., Matthews, B. R., Kao, A. W., Vossel, K. A., Tartaglia, M. C., Miller, Z. A., Seo, S. W., Sidhu, M., Gaus, S. E., Nana, A. L., Vargas, J. N. S., Hwang, J.-H. L., Ossenkoppele, R., Brown, A. B., Huang, E. J., Coppola, G., Rosen, H. J., Geschwind, D., Trojanowski, J. Q., Grinberg, L. T., Kramer, J. H., Miller, B. L., & Seeley, W. W.
- Affiliations
- University of California, San Francisco (US)
- Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA
- University of Minnesota (US)
- University of California, Los Angeles (US)
- University of Pennsylvania (US)
- Corresponding author
- Perry, David C
- ORCID
- Perry, David C
- Brown, Jesse A
- Possin, Katherine L
- Kornak, John
- Sias, Ana C
- Rabinovici, Gil D
- Boxer, Adam L
- Rankin, Katherine P
- Sturm, Virginia E
- Lee, Suzee E
- Kao, Aimee W
- Vossel, Keith A
- Tartaglia, Maria Carmela
- Miller, Zachary A
- Seo, Sang Won
- Nana, Alissa L
- Vargas, Jose Norberto S
- Ossenkoppele, Rik
- Huang, Eric J
- Coppola, Giovanni
- Rosen, Howard J
- Geschwind, Daniel
- Trojanowski, John Q
- Grinberg, Lea T
- Kramer, Joel H
- Miller, Bruce L
- Seeley, William W
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-06
- Volume
- 140
- Issue
- 12
- Pages
- 3329-3345
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841140
- OpenAlex
- W2760832975
- Cited by
- 309
- References
- 54
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 35 · 2023: 38 · 2022: 56 · 2021: 39 · 2020: 29 · 2019: 34 · 2018: 23 · 2017: 1
- FWCI
- 19.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- PMC
- Funders
- National Institutes of Health (P01AG019724, P50AG023501, P30AG10124, P01AG17856, K23AG045289, U54NS092089, R01AG038791)
- BrightFocus Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- behavioral variant frontotemporal dementia, clinicopathological correlation, frontotemporal lobar degeneration, FTLD-tau, FTLD-TDP, corticobasal degeneration, progressive supranuclear palsy, Pick's disease, motor neuron disease, Alzheimer's disease, voxel-based morphometry, brain atrophy, behavioral syndromes, disease-modifying therapy, symptom profiles, neuropathology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Autopsy, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Organ Size, Supranuclear Palsy, Progressive, Pick Disease of the Brain, Frontotemporal Lobar Degeneration, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.